 |
인쇄하기
취소
|
Sale of new oral drug for type 2 diabetes approved
A newly-developed oral drug for type 2 diabetes has received approval for production and sale from the authorities.
Duvier (lobeglitazone), the second new drug developed by Chong Kun Dang Pharm following Camtobell (belotecam) in 2003, has passed safety and effectiveness tests, becoming the 20th new drug developed by a local pharmaceutical company, the Ministry of Food and Drug Safety (MFDS) ...
Duvier (lobeglitazone), the second new drug developed by Chong Kun Dang Pharm following Camtobell (belotecam) in 2003, has passed safety and effectiveness tests, becoming the 20th new drug developed by a local pharmaceutical company, the Ministry of Food and Drug Safety (MFDS) ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.